As a neurosurgeon-scientist, Dr. Hutter witnesses the devastation that malignant brain tumors cause patients and their families first hand. His journey in academic medicine started as a resident in neuropathology, where he had a first glimpse on the complexity of human brain tumors.
Accompanying a friend from initial histopathological diagnosis to his neurological decline and death was deeply influenced his career choice. Dr. Hutter says the desire to help these patients motivates him to conduct basic and translational research, with the ultimate goal of translating research findings into clinical application.
Dr. Hutter established his research group in Basel, Switzerland in 2018 with focussing on developing combinatorial therapeutic approaches that locally target microglia and the adaptive immune system, and directly interfere with the tumor cells.